Inovio Pharmaceuticals Inc
INO
Market Cap$70.4M
Close$
$-1.24
165.8% downside
Current Fair Value
165.8% downsideOvervalued by 165.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $70.40 Million |
|---|---|
| Enterprise Value | $16.45 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.95 |
| Beta | 0.92 |
| Outstanding Shares | 27,650,680 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.63 |
| Price to Book Ratio | 0.94 |
| Enterprise Value to Revenue | 0.16 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inovio Pharmaceuticals Inc
CEO: Jong Kim